Max Drawdown (5Y) Chart

Historical Max Drawdown (5Y) Data

View and export this data back to 2012. Start Trial.
Date Value
September 30, 2026 63.99%
August 31, 2026 63.99%
July 31, 2026 63.99%
June 30, 2026 63.99%
May 31, 2026 63.99%
April 30, 2026 63.99%
March 31, 2026 63.99%
February 28, 2026 63.99%
January 31, 2026 63.99%
December 31, 2025 63.99%
November 30, 2025 63.99%
October 31, 2025 63.99%
September 30, 2025 63.99%
August 31, 2025 63.99%
July 31, 2025 63.99%
June 30, 2025 63.99%
May 31, 2025 63.99%
April 30, 2025 63.99%
March 31, 2025 63.99%
February 28, 2025 63.99%
January 31, 2025 63.99%
December 31, 2024 63.99%
November 30, 2024 63.99%
October 31, 2024 63.99%
September 30, 2024 63.99%
Date Value
August 31, 2024 63.99%
July 31, 2024 63.99%
June 30, 2024 63.99%
May 31, 2024 63.99%
April 30, 2024 63.99%
March 31, 2024 63.99%
February 29, 2024 63.99%
January 31, 2024 63.99%
December 31, 2023 63.99%
November 30, 2023 63.99%
October 31, 2023 63.99%
September 30, 2023 63.99%
August 31, 2023 63.99%
July 31, 2023 63.99%
June 30, 2023 63.99%
May 31, 2023 63.99%
April 30, 2023 63.99%
March 31, 2023 63.99%
February 28, 2023 63.99%
January 31, 2023 63.99%
December 31, 2022 63.99%
November 30, 2022 63.99%
October 31, 2022 63.99%
September 30, 2022 60.89%
August 31, 2022 60.89%

Max Drawdown Definition

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
Ottobock SE & Co. KGaA --
Abbott Laboratories 39.63%
AngioDynamics, Inc. 82.98%
Alphatec Holdings, Inc. 73.51%
AtriCure, Inc. 77.21%